Trial Review

The ANZCTR website is back online for trial registration and updates. We apologise for any inconvenience caused while the site was inactive.


With activity expected to increase on the ANZCTR again, there may be extended wait times while we process pending studies, with priority being given to those trials submitted in February. Thank you for your patience.


Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements.
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05509972




Registration number
NCT05509972
Ethics application status
Date submitted
11/08/2022
Date registered
22/08/2022
Date last updated
9/10/2024

Titles & IDs
Public title
In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Scientific title
International, Prospective, Longterm Study Comparing the Clinical Outcome and In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Secondary ID [1] 0 0
AAG-O-H-2024
Universal Trial Number (UTN)
Trial acronym
COLRAS
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Knee Arthritis 0 0
Knee Osteoarthritis 0 0
Primary Osteoarthritis of Knee Nos 0 0
Secondary Osteoarthritis of Knee Nos 0 0
Rheumatoid Arthritis of Knee 0 0
Instability, Joint 0 0
Osteonecrosis 0 0
Deformity Knee 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Osteoarthritis
Inflammatory and Immune System 0 0 0 0
Rheumatoid arthritis
Musculoskeletal 0 0 0 0
Other muscular and skeletal disorders
Cardiovascular 0 0 0 0
Diseases of the vasculature and circulation including the lymphatic system

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Devices - total knee prosthesis implantation

Columbus® DD Primary CoCr - Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr)

Columbus® DD Primary CoCr AS coated - Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) Advanced Surface


Treatment: Devices: total knee prosthesis implantation
Total Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Polyethylene wear over time
Timepoint [1] 0 0
until 10 years postoperatively
Secondary outcome [1] 0 0
Implant survival
Timepoint [1] 0 0
until 10 years postoperatively
Secondary outcome [2] 0 0
Quality of Life [EQ-5D-5L] compared to baseline
Timepoint [2] 0 0
preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Secondary outcome [3] 0 0
Progress of Clinical Outcome (Forgotten Joint Score-12) over follow-up period
Timepoint [3] 0 0
3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Secondary outcome [4] 0 0
Progress of Clinical Outcome [Oxford Knee Score] compared to baseline
Timepoint [4] 0 0
preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Secondary outcome [5] 0 0
Radiographic comparison of alignment over time
Timepoint [5] 0 0
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Secondary outcome [6] 0 0
Radiographic comparison of implant migration over time
Timepoint [6] 0 0
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Secondary outcome [7] 0 0
Radiographic comparison of tibial slope over time
Timepoint [7] 0 0
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Secondary outcome [8] 0 0
Radiographic comparison of the joint line over time
Timepoint [8] 0 0
baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Secondary outcome [9] 0 0
Adverse events / serious adverse events
Timepoint [9] 0 0
During the course of the study up to 10 years postoperatively
Secondary outcome [10] 0 0
Number of Participants with radiological complications over time
Timepoint [10] 0 0
During the course of the study up to 10 years postoperatively
Secondary outcome [11] 0 0
Biomechanical analysis of retrievals in case of revision
Timepoint [11] 0 0
During the course of the study up to 10 years postoperatively

Eligibility
Key inclusion criteria
* Indication for a primary bicondylar total knee endoprosthesis with the Columbus® DD knee prosthesis
* Written signed informed consent of patient
* Willingness and mental ability to participate at the long-term follow-up examinations
Minimum age
45 Years
Maximum age
75 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Pregnancy
* Patient age <45 and >75years
* Acute inflammatory arthritis
* Coagulation disorders (e.g. Haemophilia)

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
6/04/2023
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
30/08/2024
Sample size
Target
Accrual to date
Final
7
Recruitment in Australia
Recruitment state(s)
Recruitment outside Australia
Country [1] 0 0
Germany
State/province [1] 0 0
Baden-Württemberg

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Aesculap AG
Address
Country
Other collaborator category [1] 0 0
Commercial sector/industry
Name [1] 0 0
Raylytic GmbH
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Marius Selig
Address 0 0
Country 0 0
Phone 0 0
+49746195
Fax 0 0
Email 0 0
[email protected]
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT05509972